Anna Richo

Companies

• IlluminaBoard member May 22, 2024 to now¹
• ExelonBoard member Aug 2, 2023 to now²
• Adamas Pharmaceuticals (United States)Board member Sep 1, 2020 to Nov 24, 2021³
• AmgenSVP. WW Compliance Jun 13, 2008 to Aug 1, 2012⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Illumina ILMN8,527 shares⁵$2.2M at $262.52May 21, 2026
• Exelon EXC11,337 shares⁶$488.5K at $43.09Mar 31, 2026
• APAdamas Pharmaceuticals (United States)0 shares⁷Nov 24, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

• May 21, 2026Granted 2,072 shares at $144.83 of Illumina⁵
• Mar 31, 2026Granted 878 shares at $49.82 of Exelon⁶
• Dec 31, 2025Granted 940 shares at $43.87 of Exelon⁸
• Sep 30, 2025Granted 950 shares at $43.43 of Exelon⁹
• Jun 30, 2025Granted 954 shares at $43.25 of Exelon¹⁰
• May 21, 2025Granted 3,780 shares of Illumina¹¹
• Mar 31, 2025Granted 933 shares at $44.19 of Exelon¹²
• Dec 31, 2024Granted 1,119 shares at $36.87 of Exelon¹³
• Sep 30, 2024Granted 1,025 shares at $40.23 of Exelon¹⁴
• Jun 30, 2024Granted 1,161 shares at $35.54 of Exelon¹⁵
• May 16, 2024Granted 2,622 shares of Illumina¹⁶
• Mar 31, 2024Granted 1,131 shares at $36.48 of Exelon¹⁷
• Dec 31, 2023Granted 1,052 shares at $39.21 of Exelon¹⁸
• Sep 30, 2023Granted 674 shares at $40.58 of Exelon¹⁹
• Nov 24, 2021U 25,000 shares of Adamas Pharmaceuticals (United States)⁷